- • Up to 20% off your first purchase
- • Bulk quantities available
- • Citation Reward application
Sample Application
Supports
- Talk to our Expert:
[email protected] -
Talk to our sales:
[email protected]
Protocol Library
 |
 |
carcinoembryonic antigen (CEA) antibody and antigen (Recombinant protein)
Diagnostic carcinoembryonic antigen (CEA) antibodies (anti-carcinoembryonic antigen, anti-CEA) and antigens (recombinant carcinoembryonic antigen (CEA) protein) for Cancer CEA detection in ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA and POCT.
Go to
Neurodegenerative diseases diagnostics
products collection
>>
Product information
| Catalog No. | Description | US $ Price (per mg) |
|---|---|---|
| GMP-h-CEA-Ag01 | Recombinant human CEACAM3/CEA/CD66D/CGM1 Protein | 3090 |
| GMP-h-CEA-Ab01 | Anti-human CEACAM3/CEA/CD66D/CGM1 mouse monoclonal antibody (mAb) | 1953 |
| GMP-h-CEA-Ab02 | Anti-human CEACAM3/CEA/CD66D/CGM1 mouse monoclonal antibody (mAb) | 1953 |
| GMP-h-CEA-Ab03 | Anti-human CEACAM3/CEA/CD66D/CGM1 human monoclonal antibody (mAb) | 1953 |
| GMP-h-CEA-Ab04 | Anti-human CEACAM3/CEA/CD66D/CGM1 human monoclonal antibody (mAb) | 1953 |
Size： 1mg | 10mg | 100mg
Product Description
| Cat No. of Products | GMP-h-CEA-Ag01 |
| Product Name | Recombinant human CEACAM3/CEA/CD66D/CGM1 Protein |
| Target/Biomarker | carcinoembryonic antigen(CEA) |
| Alias of Target/Biomarker | CD66D, CEA, CGM1, CGM1a, W264, W282 |
| Expression platform | mammalian |
| Isotypes | Recombinant Antigen |
| Bioactivity validation | carcinoembryonic antigen (CEA) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in CEA level test of Cancer (breast cancer, lung cancer, breast cancer, liver cancer, pancreatic cancer, stomach cancer, ovarian cancer) and related syndrome evaluation. |
| Products description | Recombinant human CEACAM3/CEA/CD66D/CGM1 Protein was expressed in mammalian expression system and is expressed with 6 HIS tag at the C-terminus. |
| Purity | Purity: ≥95% (SDS-PAGE) |
| Application | Standard substance, positive control, ELISA test,Lateral flow immunoassay (LFIA),colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA),turbidimetric inhibition immuno assay (TINIA),immunonephelometry and POCT. |
| Formulation | Supplied as a 0.2 μM filtered solution of PBS,PH7.4. |
| Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
| Cat No. of Products | GMP-h-CEA-Ab01, GMP-h-CEA-Ab02 |
| Product Name | Anti-human CEACAM3/CEA/CD66D/CGM1 mouse monoclonal antibody (mAb) |
| Target/Biomarker | carcinoembryonic antigen(CEA) |
| Alias of Target/Biomarker | CD66D, CEA, CGM1, CGM1a, W264, W282 |
| Expression platform | CHO |
| Isotypes | Mouse IgG |
| Bioactivity validation | Human carcinoembryonic antigen (CEA) antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other carcinoembryonic antigen (CEA) antibodies in CEA level test of Cancer (breast cancer, lung cancer, breast cancer, liver cancer, pancreatic cancer, stomach cancer, ovarian cancer) and related syndrome evaluation. |
| Tag | mFc |
| Products description | Anti-human CEACAM3/CEA/CD66D/CGM1 mouse monoclonal antibody (mAb) is a monoclonal antibody produced by CHO. The antibody is ELISA validated as capture antibody and detection antibody pair. |
| Purity | Purity: ≥95% (SDS-PAGE) |
| Application | ELISA test, Lateral flow immunoassay (LFIA), colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA), turbidimetric inhibition immuno assay (TINIA), immunonephelometry and POCT. |
| Formulation | Supplied as a 0.2 μM filtered solution of PBS,PH7.4. |
| Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
| Cat No. of Products | GMP-h-CEA-Ab03, GMP-h-CEA-Ab04 |
| Product Name | Anti-human CEACAM3/CEA/CD66D/CGM1 human monoclonal antibody (mAb) |
| Target/Biomarker | carcinoembryonic antigen(CEA) |
| Alias of Target/Biomarker | CD66D, CEA, CGM1, CGM1a, W264, W282 |
| Expression platform | CHO |
| Isotypes | Human lgG1 |
| Bioactivity validation | Human carcinoembryonic antigen (CEA) antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other carcinoembryonic antigen (CEA) antibodies in CEA level test of Cancer (breast cancer, lung cancer, breast cancer, liver cancer, pancreatic cancer, stomach cancer, ovarian cancer) and related syndrome evaluation. |
| Tag | hFc |
| Products description | Anti-human CEACAM3/CEA/CD66D/CGM1 human monoclonal antibody (mAb) is a monoclonal antibody produced by CHO. The antibody is ELISA validated as capture antibody and detection antibody pair. |
| Purity | Purity: ≥95% (SDS-PAGE) |
| Application | ELISA test, Lateral flow immunoassay (LFIA), colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA), turbidimetric inhibition immuno assay (TINIA), immunonephelometry and POCT. |
| Formulation | Supplied as a 0.2 μM filtered solution of PBS,PH7.4. |
| Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
Validation Data
Click to get more Data / Case study about the product.
Target/Biomarker information
Carcinoembryonic antigens are proteins produced by some types of cancer. A carcinoembryonic antigen (CEA) diagnosis is used to check efficiency of cancer treatment. A CEA test is often carried out after surgery to check carcinoembryonic antigen levels. CEA can be used to assess different types of cancer, such as breast cancer, lung cancer, breast cancer, liver cancer, pancreatic cancer, stomach cancer, ovarian cancer
About GDU
GDU helps global diagnostic partners in high quality of raw material discovery, development, and application. GDU believes in Protein&antibody Innovation for more reliable diagnostic solutions.
Facebook
LinkedIn
Twitter
Comments